Michael S. Gilmore, PhD, Sir William Osler Professor of Ophthalmology at Harvard Medical School and Chief Scientific Officer at Mass Eye and Ear, recently received a five-year, $11,409,360 Program...

A new study led by a research team from Harvard Medical School and Mass. Eye and Ear, describes how bacteria adapted to the modern hospital environment and repeatedly cause antibiotic-resistant...

In a significant advance against drug-resistant superbugs, investigators supported by the Harvard-wide Program on Antibiotic Resistance have identified a new class of synthetic antibiotics that have...

Michael Gilmore, PhD, Sir William Osler Professor of Ophthalmology, gave two lectures in December. On December 5, he presented the Annual Neal Groman Lecture at the University of Washington, where...

Survival of mass extinctions helps to explain near indestructible properties of hospital "superbugs" 

Boston, Mass. — Leading hospital “superbugs,” known as the enterococci, arose from an...

In March 2017, Michael Gilmore, PhD, Director of the Harvard Infectious Disease Institute, chaired a blue ribbon panel that reviewed the most promising applications for the Antimicrobial Resistance...

Faculty Recognition

Dean Eliott, MD, Evangelos Gragoudas, MD, and Lucia Sobrin, MD, MPH, have been named members of the Ocular Surgery News "Retina 150" list. This is a select group of retinal...

Boston, Mass. —  Researchers at Massachusetts Eye and Ear have discovered a new mutation in a highly antibiotic-resistant strain of E. coli that resists clearance by the body’s own immune system by...